Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2014, Article ID 158165, 3 pages
http://dx.doi.org/10.1155/2014/158165
Case Report

A Rare Case of Neuromyelitis Optica Spectrum Disorder in Patient with Sjogren’s Syndrome

Icahn School of Medicine at Mount Sinai, Queens Hospital Center, Jamaica, NY 11432, USA

Received 20 June 2014; Accepted 6 November 2014; Published 19 November 2014

Academic Editor: Mehmet Soy

Copyright © 2014 Supat Thongpooswan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Delalande, J. de Seze, A. L. Fauchais et al., “Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients,” Medicine, vol. 83, no. 5, pp. 280–291, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. D. M. Wingerchuk, V. A. Lennon, C. F. Lucchinetti, S. J. Pittock, and B. G. Weinshenker, “The spectrum of neuromyelitis optica,” The Lancet Neurology, vol. 6, no. 9, pp. 805–815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. H. Min, H. J. Kim, B. J. Kim et al., “Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica,” Multiple Sclerosis, vol. 15, no. 9, pp. 1069–1076, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Estiasari, T. Matsushita, K. Masaki et al., “Comparison of clinical, immunological and neuroimaging features between anti-aquaporin-4 antibody-positive and antibody-negative Sjögren's syndrome patients with central nervous system manifestations,” Multiple Sclerosis, vol. 18, no. 6, pp. 807–816, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. R. Kolfenbach, B. J. Horner, E. D. Ferucci, and S. G. West, “Neuromyelitis optica spectrum disorder in patients with connective tissue disease and myelitis,” Arthritis Care and Research, vol. 63, no. 8, pp. 1203–1208, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. S. J. Pittock, V. A. Lennon, J. de Seze et al., “Neuromyelitis optica and non-organ-specific autoimmunity,” Archives of Neurology, vol. 65, no. 1, pp. 78–83, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. D. J. Kimbrough, K. Fujihara, A. Jacob et al., “Treatment of neuromyelitis optica: review and recommendations,” Multiple Sclerosis and Related Disorders, vol. 1, no. 4, pp. 180–187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. B. G. Weinshenker, P. C. O'brien, T. M. Petterson et al., “A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease,” Annals of Neurology, vol. 46, no. 6, pp. 878–886, 1999. View at Google Scholar
  9. M. Bonnan, R. Valentino, M. Bonnan, H. Mehdaoui, D. Smadja, and P. Cabre, “Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder,” Multiple Sclerosis, vol. 15, no. 4, pp. 487–492, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. B. M. Greenberg, K. P. Thomas, C. Krishnan, A. I. Kaplin, P. A. Calabresi, and D. A. Kerr, “Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide,” Neurology, vol. 68, no. 19, pp. 1614–1617, 2007. View at Publisher · View at Google Scholar · View at Scopus